Brandon A. Chan is a patent attorney at New York office of Duane Morris LLP and represents clients in all aspects of intellectual property law. Dr. Chan prepares and prosecutes patent applications in technologies ranging from biotechnology and chemistry to pharmaceuticals and design. In addition, he counsels clients regarding freedom-to-operate, invalidity, and non-infringement. Further, he assists clients in obtaining trademark protection and in protecting their intellectual property rights against allegations of infringement.
In 2009, Dr. Chan received his B.S. in Chemistry from the University of Michigan and in 2016, he received his Ph.D. in chemistry from Louisiana State University. Prior to attending law school, he participated in academic research focusing on the synthesis and characterization of biopolymers. He is a co-author on a number of peer-reviewed publications and a co-inventor on U.S. Patent No. 10,519,278 drawn to methods of polymerizing polypeptides.
While in law school, Dr. Chan served as Senior Managing Editor of the Michigan State Law Review as well as participated in the International Patent Drafting Competition. In 2019, he received his J.D. from Michigan State University College of Law and joined Duane Morris in September of that year.
Dr. Chan is admitted to practice law in New York and New Jersey and is admitted to practice before the United States Patent and Trademark Office.
- New York
- New Jersey
- U.S. District Court for the Southern District of New York
- U.S. District Court for the Eastern District of New York
- U.S. Court of Appeals for the Federal Circuit
- U.S. Patent and Trademark Office
- Michigan State University College of Law, J.D., magna cum laude, 2019
- Senior Managing Editor, Michigan State Law Review
- Louisiana State University, Ph.D., 2016
- University of Michigan, B.S., Chemistry, 2009
- Duane Morris LLP
- Associate, 2019-present
- Co-author, "Texas Court Will Not Delay In-Person Trial to Permit Vaccination of Participants," Duane Morris Alert, March 22, 2021
- Co-author, "Who Watches the Watchmen? Supreme Court to Decide Fate of Administrative Patent Judge Appointments," Duane Morris Alert, March 8, 2021
- Co-author, "Forum Selection Clause Held Inapplicable for Precluding Inter Partes Review Before the Patent and Trial Appeal Board," Duane Morris Alert, February 8, 2021
- Co-author, "Patent-Eligible Subject Matter in Biotech Should Recite More Than a 'Telescope'," Duane Morris Alert, December 8, 2020; reprinted in Intellectual Property & Technology Law Journal, March 2021
- Co-author, "Playing Your Cards Right: Arguments Against Obviousness Can Be Detrimental for Satisfying the Written Description Requirement," Intellectual Property & Technology Law Journal, October 2020
- Co-author, "Playing Your Cards Right: Arguments Against Obviousness Can Be Detrimental for Satisfying the Written Description Requirement," Duane Morris Alert, July 2, 2020
- Co-author, "The Capricious and Ever-Changing Nature of IP Practice Under COVID-19: Deadline Extensions, Sometimes with a Catch, and Ungracious Grace Periods," Duane Morris Alert, May 4, 2020
- Co-author, "Numerical Ranges: More Than Just Endpoints in Patent Process," Duane Morris Alert, February 14, 2020
Co-author, "Polypeptoid Polymers: Synthesis, Characterization, and Properties," Biopolymers 2017, 10.1002/bip.23070.
Co-author, "lnterfacial Ring-Opening Polymerization Amino-Acid-Derived N-Thiocarboxyanhydrides Toward Well-Defined Polypeptides," ACS Macro Lett. 2017, 6, 836-840.
Selected Speaking Engagements
- Speaker, "Alternative Career Paths: A World Outside the Lab," 2020 TAAB Virtual Symposium, Taiwanese American Association of Biotechnology, Webinar, November 21, 2020
- Speaker, "Lab Bench to Bar: Career Paths in Patent Law," Graduate Student Professional Development Seminar, Lousiana State University Department of Chemistry, Webinar, November 18, 2020
- Presenter, "Tensions Between Nonobviousness and Written Description in U.S. Patent Law," Duane Morris LLP, Webinar, October 27, 2020